Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pål Aukrust

Showing results (1-10 of 692) with videos related to

Pageof 70
Sort By:
Heart (British Cardiac Society)|July 10, 2012
The prediction of adverse cardiac remodelling following myocardial infarction: defining the need for a dynamic multimarker approachS Orn, Pål Aukrust
The American Journal of Cardiology|June 1, 2005
Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approachesLars Gullestad, Pål Aukrust
Scandinavian Cardiovascular Journal : SCJ|October 3, 2006
Systemic markers of inflammation--are they useful predictive tools in coronary artery disease?Jan K Damås, Pål Aukrust
Arteriosclerosis, Thrombosis, and Vascular Biology|August 20, 2010
Osteoprotegerin: a biomarker with many facesKenneth Caidahl, Thor Ueland, Pål Aukrust
Aging|November 8, 2019
CCL21 and prognosis in acute coronary syndromeThor Ueland, Pål Aukrust, Kenneth Caidahl
JACC. Basic to Translational Science|June 8, 2021
Targeting IL-6 Trans-Signaling: Amplifying the Benefits of IL-6 Inhibition in Myocardial InfarctionPål Aukrust, Ola Kleveland, Lars Gullestad
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 8, 2020
Sheraz Yaqub, Mohammad Usman Rana, Pål Aukrust
Thrombosis Research|July 20, 2012
Visfatin/NAMPT - a hot spot in thrombosis?Bente Halvorsen, Tuva B Dahl, Pål Aukrust
Thrombosis and Haemostasis|August 23, 2005
Early anti-thrombotic and anti-inflammatory actions of statins and fibrates--time for adjuvant therapy in acute coronary syndromes?Jan Kristian Damås, Luca Puccetti, Pål Aukrust
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 12, 2013
Intestinal Kaposi sarcoma in a lung transplant recipient: therapy with mammalian target of rapamycin inhibitor and immunosuppression reductionMay Brit Lund, Vemund Paulsen, Pål Aukrust
Pageof 70

Showing results (1-10 of 692) with videos related to

Sort By:
Pageof 70
Heart (British Cardiac Society)|July 10, 2012
The prediction of adverse cardiac remodelling following myocardial infarction: defining the need for a dynamic multimarker approachS Orn, Pål Aukrust
The American Journal of Cardiology|June 1, 2005
Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approachesLars Gullestad, Pål Aukrust
Scandinavian Cardiovascular Journal : SCJ|October 3, 2006
Systemic markers of inflammation--are they useful predictive tools in coronary artery disease?Jan K Damås, Pål Aukrust
Arteriosclerosis, Thrombosis, and Vascular Biology|August 20, 2010
Osteoprotegerin: a biomarker with many facesKenneth Caidahl, Thor Ueland, Pål Aukrust
Aging|November 8, 2019
CCL21 and prognosis in acute coronary syndromeThor Ueland, Pål Aukrust, Kenneth Caidahl
JACC. Basic to Translational Science|June 8, 2021
Targeting IL-6 Trans-Signaling: Amplifying the Benefits of IL-6 Inhibition in Myocardial InfarctionPål Aukrust, Ola Kleveland, Lars Gullestad
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 8, 2020
Sheraz Yaqub, Mohammad Usman Rana, Pål Aukrust
Thrombosis Research|July 20, 2012
Visfatin/NAMPT - a hot spot in thrombosis?Bente Halvorsen, Tuva B Dahl, Pål Aukrust
Thrombosis and Haemostasis|August 23, 2005
Early anti-thrombotic and anti-inflammatory actions of statins and fibrates--time for adjuvant therapy in acute coronary syndromes?Jan Kristian Damås, Luca Puccetti, Pål Aukrust
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 12, 2013
Intestinal Kaposi sarcoma in a lung transplant recipient: therapy with mammalian target of rapamycin inhibitor and immunosuppression reductionMay Brit Lund, Vemund Paulsen, Pål Aukrust
Pageof 70